Pumps could help poorly controlled type 2 patients

Insulin pumps could be more effective than multiple daily injections for type 2 diabetes patients who do not meet their glycated haemoglobin targets.

A randomised international study of 331 patients shows those using insulin pumps achieved a mean A1C reduction of 1.1% at six months, compared with 0.4% for those using multiple daily injections.

Those in the insulin-pump group lowered the total daily dose of insulin by more than 20%, according to the study which was designed and sponsored by pump producer Medtronic.